Omicron May Overcome Prior COVID Infection

By Robert Preidt and Ernie Mundell HealthDay Reporters FRIDAY, Dec. 3, 2021 — People who’ve already had COVID-19 have a higher risk of reinfection with the Omicron coronavirus variant than with earlier variants, new research shows. The South African scientists who reported the findings believe that vaccination will have the power to stop severe illness, […]

Continue Reading

Gene Found in Amish Helps Protect Their Hearts

By Amy Norton HealthDay Reporter FRIDAY, Dec. 3, 2021 — A rare gene variant discovered among Amish people may help lower “bad” cholesterol and protect against heart disease, a new study suggests. Researchers found that among nearly 7,000 Amish people, the gene variant was tied to reductions in both LDL cholesterol and fibrinogen — a […]

Continue Reading

Do Immune-Based Cancer Drugs Work Better in Men?

By Ernie Mundell and Robert Preidt HealthDay Reporters FRIDAY, Dec. 3, 2021 — Women are two times more likely than men to die after receiving a combination of cancer immunotherapy drugs called checkpoint inhibitors, but it’s not clear if that difference is due to side effects or because the treatment isn’t working, researchers say. This […]

Continue Reading

GSK and the University of Oxford launch new Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease

GlaxoSmithKline plc and the University of Oxford announced a major five-year collaboration to establish the Oxford-GSK Institute of Molecular and Computational Medicine. The new Institute, which will be based at the University of Oxford, aims to improve the success and speed of research and development of new medicines, building on insights from human genetics and […]

Continue Reading